Evekeo, a CII controlled substance, is the only ADHD stimulant therapy with a 1:1 racemic mixture of dextroamphetamine and levoamphetamine. Amphetamines are non-catecholamine, sympathomimetic amines with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures, and weak bronchodilator, and respiratory stimulant action.
Evekeo is also approved for the treatment of narcolepsy in patients aged ≥6 years, and for exogenous obesity as a short-term adjunctive therapy in a regimen of weight reduction in patients aged ≥12 years.
It is available in 5mg and 10mg strength tablets in 100-count bottles.
For more information call (866) 516-4950 or visit Evekeo.com.